^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ROSE12

    i
    Other names: ROSE12, ROSE 12, ROSE-12
    Associations

    News

    Trials
    Company:
    Roche
    Drug class:
    Immunostimulant, Undefined mechanism
    Related drugs:
    Associations

    News

    Trials
    over1year
    A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors (clinicaltrials.gov)
    P1, N=219, Recruiting, Chugai Pharmaceutical
    New P1 trial • Combination therapy • Metastases
    |
    Tecentriq (atezolizumab) • ROSE12